Health ❯ Pharmaceuticals ❯ Drug Approval

FDA Regulations

AstraZeneca Compounding Pharmacies Safety Testing Rare Disease Treatments Biologics License Application MOLBREEVI BLA New Drug Policies National Priority Voucher Program New Drug Entities Clinical Trials

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Class Action

Filings claim the company downplayed FDA objections to relacorilant by touting its approval prospects.

FDA Approves Vanda's Bysanti for Schizophrenia and Bipolar I in Adults

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags

RFK Jr. Overhauls HHS With Deep Cuts, MAHA Push and Vaccine Policy Reversals

Savara Investors Pressed to Seek Lead Role in Securities Suit Before Nov. 7 Deadline

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Regulators Intensify Warnings on Unregulated Nasal Tanning Sprays Over Health Risks

FDA Approves First At-Home Nasal Spray Flu Vaccine